European Companies Search Engine
EU funding (€5,234,950): NEW TECHNOLOGIES FOR AFRICAN SWINE FEVER VACCINES Hor1 Jan 2024 EU Research and Innovation programme "Horizon"
Text
NEW TECHNOLOGIES FOR AFRICAN SWINE FEVER VACCINES
VAX4ASF aims to develop a state-of-the-art platform to produce highly effective and safe vaccines against ASFV targeted for both domestic pigs and wild boars. These vaccine candidates will be designed based on an innovative and robust vaccine platform that will guarantee immune protection against the different circulating ASFV variants in Europe, while avoiding the safety concerns arisen with the use of traditional live attenuated vaccine platforms. Vaccine candidates will effectively induce innate immune response with the adequate adaptive immunity. Moreover, the immunity induced will allow discrimination between vaccinated and infected animals, which will be monitored by complementary DIVA tests developed under the scope of the project. Given the complexity of ASFV genome and the still incomplete knowledge of the mechanisms involved in immune response to ASFV, VAX4ASF aims to further understand the molecular mechanisms of the virus and how it interacts with the host. The developed platform can be used to introduce new mutations based in this new generated knowledge which will allow to improve the efficacy and cross-protection of the vaccine prototypes. VAX4ASF will provide new virus epidemiology models and control strategies using different mathematical models, leading to a better understanding of the ASFV transmission at the wild-domestic interface. In this way, innovative policies and strategies for ASFV control and management will be generated to ensure an outstanding impact through the continuous involvement of key stakeholders as project partners (farmers, wild board managers, veterinaries, hunters, policy makers...), leading to a profound effect in animal health and worldwide economy. The project relies on a solid collaboration trajectory between leading developers of innovative Animal Health vaccines and the highest experts in ASF field at international level, including partners from Europe, USA, and Kenya for the achievement of this challenge.
Funded Companies:
| Company name | Funding amount |
| KANSAS STATE UNIVERSITY | ? |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | €700,000 |
| Asociacion Interprofesional Porcino de Capa Blanca | €46,813 |
| Asociacion-Nacional de Productoresde Ganado Porcino | €92,985 |
| Hipra SA | €0.00 |
| Hipra Scientific SL | €0.00 |
| IN3Diagnostic Srl | €383,000 |
| International Livestock Research Institute | €405,125 |
| Laboratorios Hipra SA | €1,737,713 |
| LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN | €192,714 |
| Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy | €239,966 |
| PROPHYL ALLATEGESZSEGUGYI DIAGNOSZTIKAI KUTATO ES SZOLGALTATO kft. | €252,716 |
| Sabiotec Spin-Off SL | €92,594 |
| Statens Veterinaermedicinska Anstalt | €286,538 |
| STICHTING WAGENINGEN RESEARCH | €249,969 |
| Universitatea de Stiintele Vietii Regele Mihai I Din Timisoara | €61,100 |
| Zabala Innovation Consulting SA | €493,719 |
Source: https://cordis.europa.eu/project/id/101136439
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: KANSAS STATE UNIVERSITY, Kansas, United States.
The visualizations for "KANSAS STATE UNIVERSITY - EU funding (€5,234,950): NEW TECHNOLOGIES FOR AFRICAN SWINE FEVER VACCINES"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
